U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07379437) titled 'Haematococcus Pluvialis Astaxanthin for Brain Aging' on Dec. 21, 2025.
Brief Summary: We recruit community-dwelling older adults aged 50 and above for a 6-month intervention. Participants are divided into three groups:
Placebo Group, Low-Dose Group ( 6 mg/d Haematococcus pluvialis Astaxanthin), High-Dose Group (12 mg/d Haematococcus pluvialis Astaxanthin).
Peripheral blood samples and Other tests are collected at baseline, 3 months, and 6 months to measure mitochondrial function and oxidative stress levels.
Assessments include: 1.Cognitive & Neurophysiological Assessment: Using the MoCA (Montreal Cognitive Assessmentscale) and ER...